How to tell the difference and why it matters
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/ce776106-c038-424f-a506-0796e05a2f34/16-RHE-871-Calabrese-Hero-Image-650x450pxl_jpg)
16-RHE-871-Calabrese-Hero-Image-650x450pxl
By Rula Hajj-Ali, MD, and Leonard Calabrese, DO
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Primary angiitis of the central nervous system (PACNS) is a devastating disease in which exclusive inflammation and destruction of vessels in the CNS cause progressive, debilitating neurological deficits. Prognosis improves greatly with proper treatment, but with nonspecific tests and many confounding mimics, diagnosis can be tricky.
One of PACNS’s closest mimics is reversible cerebral vasoconstriction syndrome (RCVS). The distinguishing characteristic of this group is the “thunderclap” headache — sudden, severe and with or without neurological deficits. Originally, rheumatologists treated RCVS as benign angiopathy of the CNS. In 2007, Calabrese et al set forth RCVS as a concept encompassing several syndromes with unifying clinical, laboratory and radiologic features. The clinical features and diagnostic criteria described in that paper have been considered the standard since its publication.
Distinguishing between RCVS and PACNS is critical because the treatment protocol is so vastly different. Misdiagnosing PACNS as RCVS can deprive a patient of medications that prolong survival and improve outcomes. These conditions are close mimics, but the astute clinician has several tools in her armamentarium to distinguish between them. We offer a brief overview of differences in clinical presentation below. Future posts will discuss differences in test results and management.
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/de9ba078-ae7c-41ee-895d-735825fb3f39/18-RHE-1077-PACNS-or-RCVS-Visual-Abstract-1200x650pxl_04_10_2018_01b_jpg)
Patients with PACNS are more commonly male and trend older with a mean age of 50 years at onset, while patients with RCVS are more likely to be female and a bit younger. Patients with both conditions almost always present with headaches, but the differences in onset and type are important to distinguish between the mimics. Patients with PACNS experience subacute onset of headaches with focal and nonfocal deficits; a patient with sudden-onset, severe, “thunderclap” headaches should be considered for RCVS whether or not neurological deficits are present. RCVS is monophasic, but patients with PACNS will experience these symptoms chronically.
Advertisement
When patients present with these symptoms, diagnostic tests can help eliminate the mimics and narrow towards a precise diagnosis.
Dr. Hajj-Ali is Associate Director of the Center for Vasculitis Care and Research in the Department of Rheumatic and Immunologic Diseases. Dr. Calabrese is Director of the R.J. Fasenmyer Center for Clinical Immunology.
Advertisement
Advertisement
A population with very high lifetime risk presents care challenges and pathophysiologic insights
Two Cleveland Clinic neurologists review biomarker advances, targeted therapies and unresolved clinical challenges
Data-driven segmentation approach shows promise for seizure characterization with utility for clinical decision making
Alzheimer’s studies delve into preventing and modifying the disease’s trajectory and impact
Study finds broadly similar outcomes between MIS and open surgical approaches
System uses clinical data routinely collected at clinical visits
Newer protocols address testing, language and communication
Collaboration with AI startup promises to reshape neurocritical care monitoring at scale